全文获取类型
收费全文 | 255篇 |
免费 | 35篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 3篇 |
妇产科学 | 5篇 |
基础医学 | 51篇 |
口腔科学 | 1篇 |
临床医学 | 5篇 |
内科学 | 36篇 |
皮肤病学 | 1篇 |
神经病学 | 35篇 |
特种医学 | 69篇 |
外科学 | 25篇 |
综合类 | 8篇 |
预防医学 | 16篇 |
眼科学 | 3篇 |
药学 | 13篇 |
肿瘤学 | 25篇 |
出版年
2023年 | 6篇 |
2022年 | 4篇 |
2021年 | 13篇 |
2020年 | 16篇 |
2019年 | 40篇 |
2018年 | 19篇 |
2017年 | 14篇 |
2016年 | 10篇 |
2015年 | 16篇 |
2014年 | 15篇 |
2013年 | 14篇 |
2012年 | 8篇 |
2011年 | 15篇 |
2010年 | 8篇 |
2009年 | 2篇 |
2008年 | 13篇 |
2007年 | 5篇 |
2006年 | 15篇 |
2005年 | 5篇 |
2004年 | 4篇 |
2003年 | 5篇 |
2002年 | 2篇 |
2001年 | 5篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1990年 | 3篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 6篇 |
1984年 | 1篇 |
1983年 | 4篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有299条查询结果,搜索用时 15 毫秒
61.
Satoshi Iguchi Hirohiko Imai Yuki Hori Junichi Nakajima Atsuomi Kimura Hideaki Fujiwara 《Magnetic resonance in medicine》2013,70(1):207-215
MRI of hyperpolarized 129Xe dissolved in pulmonary tissues, and blood has the potential to offer a new tool for regional evaluation of pulmonary gas exchange and perfusion; however, the extremely short T and low magnetization density make it difficult to acquire the image. In this study, an ultrashort echo‐time sequence was introduced, and its feasibility to quantitatively assess emphysema‐like pulmonary tissue destruction by a combination of dissolved‐ and gas‐phase 129Xe lung MRI was investigated. The ultrashort echo‐time has made it possible to acquire dissolved 129Xe images with reasonably high spatial resolution of 0.625 × 0.625 mm2 and to obtain T of 0.67 ± 0.30 ms in a spontaneously breathing mouse at 9.4 T. The regional dynamic alveolar gas uptake as well as subsequent transport by pulmonary blood flow was also visualized. The ratio of 129Xe magnetization that diffused into the septa relative to the gas‐phase magnetization F was regionally evaluated. The mean F value of elastase‐treated mice was 2.28 ± 0.46%, which was significantly reduced from that of control mice 3.41 ± 0.48% (P = 0.0052). This reflects the reduced uptake efficiency due to alveolar tissue destruction and is correlated with the histologically derived alveolar surface‐to‐volume ratio. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
62.
63.
Thomas J. Moran 《Archives of environmental & occupational health》2013,68(5):267-276
Review of 2895 consecutive autopsies from 1962 to 1980 inclusive showed no significant differences in the prevalence of emphysema or other chronic lung disease between 282 active and retired employees of a cotton textile mill and the nontextile population. There was no statistical evidence that exposure to cotton dust, even after many years, produced emphysema, interstitial fibrosis, or cor pulmonale. The prevalence of emphysema in the series was highest in white males (22.0%), followed closely by black males (18.3%). In white females it was 7.5%, in black females, 5.5%. The prevalence in subjects under age 50 yr was 4.5%; in the age group 60-64 yr, 14.6%; and in subjects 65 yr of age and older, 21.9%. A significant increase in the prevalence of emphysema occurred between the 1962 to 1969 period and the 1970 to 1980 period. 相似文献
64.
65.
131I is one of the most important radionuclides used in nuclear medicine. The accompanying isotope 129I with insignificant activities in 131I-pharmaceuticals, produced in THOR, were determined in terms of 129I/131I ratio by neutron activation analysis. The detection limit of 129I can be lowered to order of 0.1 Bq, superior to conventional radiometric methods. The 129I/131I ratios in the 131I-pharmaceuticals, were measured to be in the range from 3.9 to 8.3. 相似文献
66.
67.
Enriqueta Felip Fabrice Barlesi Benjamin Besse Quincy Chu Leena Gandhi Sang-We Kim Enric Carcereny Lecia V. Sequist Paal Brunsvig Christos Chouaid Egbert F. Smit Harry J.M. Groen Dong-Wan Kim Keunchil Park Emin Avsar Sebastian Szpakowski Mikhail Akimov Edward B. Garon 《Journal of thoracic oncology》2018,13(4):576-584
Introduction
In this phase 2 study, we evaluated the activity of AUY922 in pretreated patients with stage IV NSCLC.Methods
Patients with advanced NSCLC were divided into molecularly defined strata based on mutations in the EGFR gene, the ALK receptor tyrosine kinase gene (ALK), the KRAS gene, or the wild type of all three. All patients must have received more than two prior lines of therapy, except for those in a fifth stratum for a less pretreated EGFR cohort (EGFR<2). In the EGFR-mutant and ALK-rearranged strata, prior platinum therapy was not required. Patients with EGFR mutation must have received an EGFR tyrosine kinase inhibitor unless they had de novo resistance (e.g., T790M or exon 20 insertions). Eligible patients received weekly intravenous AUY922, 70 mg/m2. The primary objective was to estimate efficacy (complete or partial response, or in the absence of complete or partial response, stable disease) at 18 weeks, by the Response Criteria in Solid Tumors.Results
A total of 153 patients from 21 global centers were enrolled from October 2010 to November 2014. The investigator-assessed overall response rate and stable disease rate at 18 weeks were 31.8% and 9.1% in the ALK-rearranged stratum, 17.1% and 8.6% in EGFR-mutant stratum, 9.7% and 22.6% in the EGFR<2 stratum, 0% and 7.1% in KRAS-mutant stratum, and 8.8% and 8.8% in wild-type stratum. Biomarker data showed activity of AUY922 in EGFR-mutant patients with exon 19 deletion, T790M mutation, and exon 20 insertion. The most common (≥40%) all-causality adverse events were diarrhea, nausea, and decreased appetite. Visual-related disorders were reported in 79.7% of patients (most were grade 1/2). Thirty-five patients (22.9%) reported night blindness.Conclusion
AUY922 is active in patients with NSCLC, particularly among patients with ALK rearrangements and EGFR mutations. 相似文献68.
69.
70.